Related Experiment Video
Updated: Sep 28, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution
1Wyeth-Lederle Vaccines, 211 Bailey Road, W. Henrietta, NY 14586, USA. Hausdowp@war.wyeth.com
Insights
Invasive pneumococcal disease (IPD) incidence in US children remains high compared to Europe, with consistent vaccine serogroup prevalence. Geographic and temporal IPD variations may stem from differences in culturing rates and antibiotic resistance.
Area of Science:
- Epidemiology
- Infectious Diseases
- Pediatrics
Background:
- Invasive pneumococcal disease (IPD) poses a significant global health burden, particularly in young children.
- Understanding geographic and temporal variations in IPD epidemiology is crucial for effective public health strategies.
Purpose of the Study:
- To analyze geographic and temporal variability in IPD epidemiology among young children.
- To compare IPD incidence and serogroup distribution between the United States, Europe, and Latin America.
Main Methods:
- Systematic review of published studies from the United States, Europe, and Latin America.
- Analysis of surveillance data from the US Centers for Disease Control and Prevention (CDC) and the Danish national surveillance system.
- Retrospective analysis of hospital data spanning up to 40 years.
Main Results:
- US IPD incidence in children under 5 years has shown little temporal variation over the past 5 years.
- Denmark reported a 3-4 fold increase in bacteremic IPD in children under 5 over 15 years, yet US incidence remains 4-8 fold higher.
- Seven vaccine-targeted serogroups consistently account for 80%-90% of IPD in North American children, compared to 10%-20% less in European children.
Conclusions:
- Apparent temporal and geographic differences in IPD epidemiology may be influenced by variations in blood culturing rates.
- Antibiotic resistance levels and precise age distributions of studied populations likely contribute to observed epidemiological disparities.
- Consistent dominance of vaccine serogroups in causing IPD highlights the importance of pneumococcal conjugate vaccines.
Unlabelled:
We examined published studies from the United States, Europe, and Latin America to better understand geographic and temporal variability in the epidemiology of invasive pneumococcal disease (IPD) in young children. A comparison of IPD incidence levels reported for children <5 years of age within the United States (CDC) surveillance system over the past 5 years revealed little variation over that time period. Within the Danish national surveillance system, a 3-4 fold increase in bacteremic IPD in that age group was reported over the past 15 years. Nonetheless, the United States IPD incidence remains 4-8 fold higher than that reported for Denmark or other Western European countries. A retrospective analysis at one North American hospital spanning 40 years indicated that the seven serogroups represented in the licensed pneumococcal conjugate vaccine (4, 6, 9, 14, 18, 19, 23) consistently comprised 80%-90% of all serogroups causing IPD in young children. More recent retrospective comparisons in Spain, the United Kingdom, France, Belgium, and Denmark suggest modest increases in vaccine serogroup coverage over the past 10-20 years. However, in European children vaccine serogroups consistently account for 10%-20% less of the overall IPD burden as compared to North American children.
Conclusion:
factors that likely underlie a significant proportion of these apparent temporal and geographic differences include variability in blood culturing rates, in antibiotic resistance levels, and in the precise age distributions of the populations studied.
Related Concept Videos
Infectious Diseases and Their Occurrence
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Malaria

